Industry Insights

  1. Driving Change of Implementing In-Line Conditioning
    2/1/2018

    The large buffer volumes required for biomanufacturing can be a bottleneck, especially when scaling up. Just-in-time buffer preparation can be the solution.

  2. Cost Savings And Speed: The Untapped Value Of A Single-Source Solution
    9/7/2017

    Small and emerging companies face significant challenges in today’s market. This calls for an alternative solution to help them achieve success.

  3. Staying Flexible In Biomanufacturing
    12/7/2018

    The concept of optionality is key to staying flexible in biomanufacturing by keeping your options open and having multiple pathways to take while navigating through this highly uncertain environment. 

  4. Selectivity In Size Exclusion Chromatography (SEC): It’s Much More Than Average Pore Diameter (Å)
    5/22/2019

    Describing the pore of a size exclusion chromatography resin with a single number such as average pore diameter is an oversimplification. The formation of pores is dependent on complex combinations of many parameters.

  5. Targeted Therapies Drive Need For Flexible, Small-Volume Manufacturing
    5/2/2018

    Biologics, orphan drugs, and precision medicine are on the rise, and that means some big changes for drug development and manufacturing companies.

  6. How To Rapidly Create Single-Use Biomanufacturing Capacity
    6/8/2017

    To meet therapy production demands, the industry needs to have the right capacity, in the right locations. Increasingly, single-use technologies are being seen as flexible and cost-effective solutions.

  7. Choosing The Right Single-Use Bioreactor Platform
    6/8/2017

    When selecting a bioreactor, It is important that this core technology is carefully chosen, specified, designed, and supported, both now and in the future.

  8. Translating Biopharma Knowledge To Cell And Gene Therapies
    5/6/2019

    Streamlining, connecting, and automating workflows to shape the future of cellular treatment delivery has the potential to transform how we treat and potentially cure once life-threatening diseases.

  9. Evolution Of Sequencing Technology For Genomics Applications
    2/14/2019

    Since 2003, after the completion of the Human Genome project, significant progress has been made in sequencing. read how sequencing technologies have revealed astonishing data over the last ten years for multiple species.

  10. How Biopharma Is Capitalizing On The Antibody Boom
    10/10/2018

    Antibodies continue to dominate. Analyzing the strategies employed by successful players in the field could provide invaluable lessons for those hoping to enter it.